Samsung Bioepis and Organon shared that the Food and Drug Administration has designated the Hadlima (adalimumab-bwwd) high- and low-concentration (40 mg/0.4 ml, 40 mg/0.8 ml) autoinjectors and ...

- Orphan Drug Designation program provides orphan status to medications intended for the safe and effective treatment, diagnosis or prevention of rare diseases - HS, a chronic, immune-mediated skin ...

A Humira biosimilar, produced by drug maker Sandoz, has been given the green light from the US Food and Drug Administration (FDA). Sandoz, a division of Novartis, confirmed that the FDA granted ...

This drug has boxed warnings. These are the most serious warnings from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients about drug effects that may be dangerous.

(Reuters) - Drugmaker AbbVie and Icelandic biopharma company Alvotech have settled a legal fight over Alvotech's proposed generic version of AbbVie's blockbuster arthritis drug Humira, according to an ...

Jan 31 (Reuters) - Amgen Inc (AMGN.O), opens new tab said on Tuesday it launched a biosimilar version of AbbVie Inc's (ABBV.N), opens new tab big selling arthritis treatment, the first such ...